Karen Allison | Medicine and Health Sciences | Best Researcher Award

Karen Allison | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr Karen Allison, University of Rochester, United States

Assoc. Prof. Dr. Karen Allison is a dedicated ophthalmologist specializing in glaucoma care πŸ‘οΈβ€πŸ—¨οΈ. She holds a Doctor of Medicine from Robert Wood Johnson Medical School (1990) πŸŽ“ and an MBA from George Washington University (2013). Currently at the Flaum Eye Institute, she serves as Glaucoma Service Chief and Fellowship Director πŸ‘©β€βš•οΈ. With extensive experience in clinical research and education, Dr. Allison has authored impactful studies on glaucoma, disparities in healthcare, and genetic factors in ocular diseases πŸ“šπŸ§¬. Her accolades include Leading Physicians in the World and the Women of Distinction honors 🌟. She’s a passionate advocate for diversity and health equity πŸ’™.

Publication Profile

Orcid

Education

Associate Professor Dr. Karen Allison holds a Doctor of Medicine (M.D.) degree from the University of Medicine and Dentistry of New Jersey (Robert Wood Johnson Medical School), earned in May 1990 πŸ©ΊπŸ“š. Further enhancing her expertise, she pursued a Master of Business Administration (M.B.A.) at The George Washington University in Washington, D.C., graduating in January 2013 πŸŽ“πŸ’Ό. With a strong foundation in both medicine and business, Dr. Allison combines her clinical acumen and strategic leadership to excel in academia and healthcare management 🌟🌐. Her interdisciplinary background empowers her to contribute meaningfully to education, research, and organizational development. πŸŒΏπŸ“–

Certifications and Professional ExperienceΒ 

Assoc. Prof. Dr. Karen Allison is a board-certified ophthalmologist with extensive expertise in both private practice and academia. 🌟 Her significant contributions at the Flaum Eye Institute include serving as Glaucoma Fellowship Director and Glaucoma Service Chief, showcasing her leadership and dedication to advancing ophthalmic care. πŸ‘οΈβ€πŸ—¨οΈ With a deep commitment to education and innovation in glaucoma management, she bridges clinical excellence with academic rigor. πŸ“šπŸ’‘ Dr. Allison’s efforts reflect her unwavering passion for improving patient outcomes and mentoring future ophthalmologists, solidifying her reputation as a respected figure in the field of ophthalmology. πŸ₯🌿

Editorial Roles and RecognitionΒ 

Assoc. Prof. Dr. Karen Allison is a leading figure in ophthalmic research and clinical practice πŸŒŸπŸ‘οΈβ€πŸ—¨οΈ. Her editorial roles in prestigious journals, including the Cureus Journal of Medical Science and the Journal of Medical Case Reports πŸ“šπŸ–‹οΈ, underscore her commitment to advancing the field. Through her peer-reviewed publications in high-impact journals πŸ“°πŸ“ˆ, Dr. Allison has made significant contributions to the academic community, fostering innovation and knowledge sharing. Her dedication to excellence in research and clinical care continues to inspire professionals and students alike, driving progress in ophthalmology and beyond πŸŒπŸ”¬.

Awards and HonorsΒ 

Assoc. Prof. Dr. Karen Allison is a distinguished ophthalmologist honored with multiple accolades for her contributions to the field and community. She was featured in the Nationwide Registries Women of Distinction Honors Edition in 2021, and recognized as one of the Leading Physicians in the World in 2013. Dr. Allison was named a Top Ophthalmologist in New York in 2013 and 2014. Her dedication to community service earned her awards from the Lions Club of Brooklyn-Kings County in 2013 and the St. Kitts Organization in 2007. πŸŒŸπŸ‘©β€βš•οΈπŸ…πŸŒ

Research Supervision and MentorshipΒ 

Assoc. Prof. Dr. Karen Allison is dedicated to shaping the next generation of researchers. Her commitment shines through her creation of the glaucoma intern research fellowship, which provides invaluable hands-on experience. Beyond that, she has mentored high school students, medical students, and residents, fostering their growth through guidance and supervision of impactful research. This personalized, nurturing approach to education makes her an exceptional academic mentor, helping students thrive in both clinical and research settings. Her passion for teaching and research mentorship is truly inspiring. πŸ§‘β€πŸ«πŸ”¬πŸ‘©β€πŸ”¬πŸ’‘πŸ“š

Research Focus

Assoc. Prof. Dr. Karen Allison’s research primarily focuses on ocular health disparities, particularly glaucoma and age-related macular degeneration (AMD). Her work examines racial, ethnic, and gender disparities in eye care access and treatment, analyzing patterns in gene expression and clinical outcomes across different populations. She evaluates the impact of socioeconomic factors on the utilization of eye care services, leveraging data from sources like the CDC’s Behavioral Risk Factor Surveillance System. Her studies also delve into the genetic underpinnings of eye diseases, seeking to better understand variations in macular tissues and their role in AMD progression. πŸ‘οΈπŸ“ŠπŸ§¬πŸ‘©β€πŸ”¬

Publication Top Notes

Tracey Young-Sharma | Medicine and Health Sciences | Best Researcher Award

Tracey Young-Sharma | Medicine and Health Sciences | Best Researcher Award

Dr Tracey Young-Sharma, Ministry of Health and Medical Service FIji, Fiji

Dr. Tracey Young-Sharma is an accomplished physician specializing in internal medicine and antimicrobial resistance (AMR). She holds a Masters of Medicine from Fiji National University (2019) and has been awarded the ASID GOLD Medal. Currently an AMR consultant for the World Health Organization, Dr. Young-Sharma has held various roles, including Consultant Physician and Registrar at CWM Hospital. She has contributed to multiple studies on antimicrobial resistance and its impact in Fiji, with notable publications in The Lancet and JGAR. Dr. Young-Sharma is also the Chairperson of the Infection Prevention Control Committee at CWMH. πŸ₯πŸ¦ πŸ“šπŸŒ

Publication Profile

Scopus

Education

Dr. Tracey Young-Sharma is a highly accomplished medical professional with a strong background in Internal Medicine. She completed her Masters of Medicine in Internal Medicine at Fiji National University in 2019. Prior to that, she earned a Postgraduate Diploma in Internal Medicine in 2016 and a Bachelor’s degree in Medicine and Surgery from the Fiji School of Medicine in 2010. Dr. Young-Sharma has been recognized for her excellence in the field, receiving the prestigious Australian Society of Infectious Disease (ASID) GOLD Medal Award πŸ…πŸ’‰. Her dedication to improving healthcare continues to inspire and impact the medical community. πŸ‘©β€βš•οΈπŸŒŸ

Experience

Dr. Tracey Young-Sharma is an AMR consultant for the World Health Organisation (WHO) since August 2024 🌍. Previously, she served as a Consultant Physician at CWM Hospital (2022-2024) πŸ₯ and as a Registrar at the same hospital from 2016 to 2021. Prior to that, she worked as a Registrar in Internal Medicine at Labasa Hospital in 2015 🩺. Dr. Young-Sharma began her career as a Medical Officer at Levuka Hospital and Koro Health Centre (2012-2014) πŸ₯ and completed her internship at CWM Hospital in 2011. Her extensive experience spans various medical roles, contributing to healthcare development. πŸ‘©β€βš•οΈπŸŒΏ

Professional MembershipsΒ 

Dr. Tracey Young-Sharma is a dedicated healthcare professional with strong affiliations in the medical field. She is an Associate Member of the Internal Medicine Society of Australia and New Zealand and a member of the Internal Medicine Organisation of the Pacific. Additionally, Dr. Young-Sharma is part of the International Women’s Association, the Fiji Medical Association, and the Australasian College of Infection Prevention and Control. In 2022, she served as the Chairperson of the Infection Prevention and Control Committee at CWMH. Her active roles reflect her commitment to advancing healthcare and fostering collaboration in the medical community. πŸŒπŸ‘©β€βš•οΈπŸ’‰πŸ©Ί

Research Focus

Dr. Tracey Young-Sharma’s research primarily focuses on antimicrobial resistance (AMR), particularly in resource-limited settings like Fiji. Her work involves genomic surveillance and epidemiological studies to understand the spread of carbapenem-resistant organisms and other multidrug-resistant pathogens. Dr. Young-Sharma’s studies also emphasize the impact of AMR on healthcare outcomes, including attributable mortality and length of hospital stays. She is also involved in improving healthcare workers’ knowledge and readiness to combat AMR through intervention studies. Her research aims to inform public health strategies and healthcare policies in the context of global AMR challenges. πŸ¦ πŸ”¬πŸŒπŸ‘©β€πŸ”¬πŸ’‰

Publication Top Notes

Successful management of a multi-species outbreak of carbapenem-resistant organisms in Fiji: a prospective genomics-enhanced investigation and response

Knowledge, attitudes, and readiness about critical antimicrobial resistant organisms among healthcare workers at colonial war memorial hospital in Fiji: a pre and post intervention study

The epidemiology of enterococci in a tertiary hospital and primary healthcare facilities in Fiji (2019–2022)

The changing epidemiology of antimicrobial resistance in Fiji: a descriptive analysis of antimicrobial susceptibility and trends of endemic and emerging pathogens, 2019–2022

Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji

Epidemiology, antimicrobial resistance and outcomes of Staphylococcus aureus bacteraemia in a tertiary hospital in Fiji: A prospective cohort study

Russka Shumnalieva | Medicine and Health Sciences | Best Researcher Award

Russka Shumnalieva | Medicine and Health Sciences | Best Researcher Award

Assist Prof Dr Russka Shumnalieva, Medical University-Sofia, Bulgaria, Bulgaria

Based on the details provided, Assist. Prof. Dr. Russka Shumnalieva appears to be a strong candidate for a Best Researcher Award.

Publication profileΒ 

Orcid

  1. Expertise in Rheumatology: Dr. Shumnalieva has extensive experience in rheumatology, working at the largest university clinic for rheumatic diseases in Bulgaria. Her PhD thesis focuses on epigenetic modifications and their relation to rheumatic diseases, demonstrating in-depth research in disease mechanisms.
  2. Clinical Integration: Her research not only addresses theoretical aspects but also their application in clinical practice. Her work includes utilizing advanced techniques such as MSUS, capillaroscopy, and mini-invasive arthroscopy, showcasing her hands-on expertise in treating and monitoring patients.
  3. Translational Medicine Experience: Her fellowship at GBRC (Glasgow) and AMC (Amsterdam) provided her valuable experience in translational medicine, bridging the gap between laboratory research and clinical application.
  4. COVID-19 Research Contributions: Dr. Shumnalieva has co-authored significant research papers in top-tier journals, contributing to global studies on COVID-19 and its impact on autoimmune diseases, which underscores her relevance in current medical challenges.
  5. Multidisciplinary Collaborations: Her publications involve multidisciplinary, international collaborations on critical topics such as coronary artery diseases in vasculitides, multimorbidity in inflammatory myopathies, and lung involvement in systemic sclerosis.
  6. Public Health and Patient Care: With a Master’s in Public Health, Dr. Shumnalieva also explores the correlation between risk factors and rheumatic diseases, adding a valuable population health perspective to her research.
  7. Publication Record: With a solid portfolio of peer-reviewed articles in highly respected journals like Rheumatology International and International Journal of Rheumatic Diseases, Dr. Shumnalieva’s research addresses critical issues like the effect of multimorbidity on quality of life and disease flares post-COVID-19 infection.

    Publication top notes

    Dr. Shumnalieva’s extensive research background, innovative approaches to rheumatology, and contributions to understanding the intersection of autoimmune diseases and COVID-19 make her a standout candidate for the Best Researcher Award.